Cargando…

Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database

Background: Monoclonal gammopathy of undetermined significance (MGUS) is a non-malignant precursor of multiple myeloma (MM). MGUS has been suggested to be associated with a higher risk of cardiovascular diseases, including AFIB, but it is still unclear whether this association is real. Studies are l...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamadi, Rachelle, Alameddine, Zakaria, Asmar, Samer, Sakr, Fouad, Aridi, Hussam, Dimachkie, Reem, Skouri, Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342272/
https://www.ncbi.nlm.nih.gov/pubmed/37445471
http://dx.doi.org/10.3390/jcm12134436
_version_ 1785072459547934720
author Hamadi, Rachelle
Alameddine, Zakaria
Asmar, Samer
Sakr, Fouad
Aridi, Hussam
Dimachkie, Reem
Skouri, Hadi
author_facet Hamadi, Rachelle
Alameddine, Zakaria
Asmar, Samer
Sakr, Fouad
Aridi, Hussam
Dimachkie, Reem
Skouri, Hadi
author_sort Hamadi, Rachelle
collection PubMed
description Background: Monoclonal gammopathy of undetermined significance (MGUS) is a non-malignant precursor of multiple myeloma (MM). MGUS has been suggested to be associated with a higher risk of cardiovascular diseases, including AFIB, but it is still unclear whether this association is real. Studies are lacking on the impact of atrial fibrillation on health outcomes in this population. The association of AFIB in this population is lagging and merits further investigation. Methods: The study conducted a retrospective analysis of the Nationwide Inpatient Sample (NIS) for 2018, including adult patients with primary diagnoses of MGUS and AFIB. Patients were divided into two groups based on AFIB presence. Outcomes assessed included complications, length of stay, mortality, hospital charges, and discharge disposition. Results: The study included 9007 patients with MGUS of whom 2404 had AFIB. Patients with both MGUS and AFIB had higher rates of acute kidney injury [AKI] (31.5% vs. 27.5%; p = 0.002) and pericarditis (2% vs. 1.2%; p = 0.029). They also had longer hospital stays (5 vs. 4 days; p < 0.001) and higher hospitalization costs ($43,729 vs. $41,169; p < 0.001). Conclusions: The study showed that the prevalence of AFIB in MGUS patients is high. Patients with AFIB had increased rates of complications (AKI and pericarditis) and higher mortality compared to patients without AFIB. Further studies screening for AFIB in this patient population are warranted.
format Online
Article
Text
id pubmed-10342272
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103422722023-07-14 Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database Hamadi, Rachelle Alameddine, Zakaria Asmar, Samer Sakr, Fouad Aridi, Hussam Dimachkie, Reem Skouri, Hadi J Clin Med Article Background: Monoclonal gammopathy of undetermined significance (MGUS) is a non-malignant precursor of multiple myeloma (MM). MGUS has been suggested to be associated with a higher risk of cardiovascular diseases, including AFIB, but it is still unclear whether this association is real. Studies are lacking on the impact of atrial fibrillation on health outcomes in this population. The association of AFIB in this population is lagging and merits further investigation. Methods: The study conducted a retrospective analysis of the Nationwide Inpatient Sample (NIS) for 2018, including adult patients with primary diagnoses of MGUS and AFIB. Patients were divided into two groups based on AFIB presence. Outcomes assessed included complications, length of stay, mortality, hospital charges, and discharge disposition. Results: The study included 9007 patients with MGUS of whom 2404 had AFIB. Patients with both MGUS and AFIB had higher rates of acute kidney injury [AKI] (31.5% vs. 27.5%; p = 0.002) and pericarditis (2% vs. 1.2%; p = 0.029). They also had longer hospital stays (5 vs. 4 days; p < 0.001) and higher hospitalization costs ($43,729 vs. $41,169; p < 0.001). Conclusions: The study showed that the prevalence of AFIB in MGUS patients is high. Patients with AFIB had increased rates of complications (AKI and pericarditis) and higher mortality compared to patients without AFIB. Further studies screening for AFIB in this patient population are warranted. MDPI 2023-06-30 /pmc/articles/PMC10342272/ /pubmed/37445471 http://dx.doi.org/10.3390/jcm12134436 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hamadi, Rachelle
Alameddine, Zakaria
Asmar, Samer
Sakr, Fouad
Aridi, Hussam
Dimachkie, Reem
Skouri, Hadi
Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
title Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
title_full Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
title_fullStr Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
title_full_unstemmed Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
title_short Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
title_sort outcomes of patients with monoclonal gammopathy of undetermined significance with and without atrial fibrillation: a retrospective cohort analysis of the nationwide inpatient sample database
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342272/
https://www.ncbi.nlm.nih.gov/pubmed/37445471
http://dx.doi.org/10.3390/jcm12134436
work_keys_str_mv AT hamadirachelle outcomesofpatientswithmonoclonalgammopathyofundeterminedsignificancewithandwithoutatrialfibrillationaretrospectivecohortanalysisofthenationwideinpatientsampledatabase
AT alameddinezakaria outcomesofpatientswithmonoclonalgammopathyofundeterminedsignificancewithandwithoutatrialfibrillationaretrospectivecohortanalysisofthenationwideinpatientsampledatabase
AT asmarsamer outcomesofpatientswithmonoclonalgammopathyofundeterminedsignificancewithandwithoutatrialfibrillationaretrospectivecohortanalysisofthenationwideinpatientsampledatabase
AT sakrfouad outcomesofpatientswithmonoclonalgammopathyofundeterminedsignificancewithandwithoutatrialfibrillationaretrospectivecohortanalysisofthenationwideinpatientsampledatabase
AT aridihussam outcomesofpatientswithmonoclonalgammopathyofundeterminedsignificancewithandwithoutatrialfibrillationaretrospectivecohortanalysisofthenationwideinpatientsampledatabase
AT dimachkiereem outcomesofpatientswithmonoclonalgammopathyofundeterminedsignificancewithandwithoutatrialfibrillationaretrospectivecohortanalysisofthenationwideinpatientsampledatabase
AT skourihadi outcomesofpatientswithmonoclonalgammopathyofundeterminedsignificancewithandwithoutatrialfibrillationaretrospectivecohortanalysisofthenationwideinpatientsampledatabase